Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.
52W Range
66thpctl
Volume
0.37×avg
Market Cap
1.27BUSD
P/E Ratio
-7.5TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Jade Biosciences, Inc.
JBIONASDAQ Global Market·USD·Closed
Jade Biosciences, Inc.
JBIONASDAQ·USD·Closed
$20.84
−2.11%
$20.84
−$0.45 (2.11%)
52W Range
66thpctl
Volume
0.37×avg
Mkt Cap
1.27BUSD
P/E
-7.5TTM
Div Yield
–ann
JBIO: Jade Biosciences, Inc. Stock Analysis | finqOS
